Copyright Reports & Markets. All rights reserved.

Global Drug Delivery System in Vivo Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug Delivery System in Vivo Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Carrier Formulation Delivery
    • 1.3.3 Targeted Delivery
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Drug Delivery System in Vivo Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Small Molecule Drug
    • 1.4.3 Proteins and Peptides
    • 1.4.4 Antibody
    • 1.4.5 Nucleic Acids
    • 1.4.6 Others
  • 1.5 Global Drug Delivery System in Vivo Market Size & Forecast
    • 1.5.1 Global Drug Delivery System in Vivo Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Drug Delivery System in Vivo Sales Quantity (2021-2032)
    • 1.5.3 Global Drug Delivery System in Vivo Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Amgen
    • 2.1.1 Amgen Details
    • 2.1.2 Amgen Major Business
    • 2.1.3 Amgen Drug Delivery System in Vivo Product and Services
    • 2.1.4 Amgen Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Amgen Recent Developments/Updates
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Drug Delivery System in Vivo Product and Services
    • 2.2.4 Teva Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Teva Recent Developments/Updates
  • 2.3 Roche
    • 2.3.1 Roche Details
    • 2.3.2 Roche Major Business
    • 2.3.3 Roche Drug Delivery System in Vivo Product and Services
    • 2.3.4 Roche Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Roche Recent Developments/Updates
  • 2.4 UCB (Union Chimique Belge)
    • 2.4.1 UCB (Union Chimique Belge) Details
    • 2.4.2 UCB (Union Chimique Belge) Major Business
    • 2.4.3 UCB (Union Chimique Belge) Drug Delivery System in Vivo Product and Services
    • 2.4.4 UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 UCB (Union Chimique Belge) Recent Developments/Updates
  • 2.5 Celgene
    • 2.5.1 Celgene Details
    • 2.5.2 Celgene Major Business
    • 2.5.3 Celgene Drug Delivery System in Vivo Product and Services
    • 2.5.4 Celgene Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Celgene Recent Developments/Updates
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Drug Delivery System in Vivo Product and Services
    • 2.6.4 Merck Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Merck Recent Developments/Updates
  • 2.7 Gilead Sciences
    • 2.7.1 Gilead Sciences Details
    • 2.7.2 Gilead Sciences Major Business
    • 2.7.3 Gilead Sciences Drug Delivery System in Vivo Product and Services
    • 2.7.4 Gilead Sciences Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Gilead Sciences Recent Developments/Updates
  • 2.8 Sanofi
    • 2.8.1 Sanofi Details
    • 2.8.2 Sanofi Major Business
    • 2.8.3 Sanofi Drug Delivery System in Vivo Product and Services
    • 2.8.4 Sanofi Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sanofi Recent Developments/Updates
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Drug Delivery System in Vivo Product and Services
    • 2.9.4 Pfizer Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Pfizer Recent Developments/Updates
  • 2.10 Takeda
    • 2.10.1 Takeda Details
    • 2.10.2 Takeda Major Business
    • 2.10.3 Takeda Drug Delivery System in Vivo Product and Services
    • 2.10.4 Takeda Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Takeda Recent Developments/Updates
  • 2.11 Bausch&Lomb
    • 2.11.1 Bausch&Lomb Details
    • 2.11.2 Bausch&Lomb Major Business
    • 2.11.3 Bausch&Lomb Drug Delivery System in Vivo Product and Services
    • 2.11.4 Bausch&Lomb Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Bausch&Lomb Recent Developments/Updates
  • 2.12 Samyang Biopharmaceuticals
    • 2.12.1 Samyang Biopharmaceuticals Details
    • 2.12.2 Samyang Biopharmaceuticals Major Business
    • 2.12.3 Samyang Biopharmaceuticals Drug Delivery System in Vivo Product and Services
    • 2.12.4 Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Samyang Biopharmaceuticals Recent Developments/Updates
  • 2.13 Johnson & Johnson
    • 2.13.1 Johnson & Johnson Details
    • 2.13.2 Johnson & Johnson Major Business
    • 2.13.3 Johnson & Johnson Drug Delivery System in Vivo Product and Services
    • 2.13.4 Johnson & Johnson Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Johnson & Johnson Recent Developments/Updates
  • 2.14 TOLMAR
    • 2.14.1 TOLMAR Details
    • 2.14.2 TOLMAR Major Business
    • 2.14.3 TOLMAR Drug Delivery System in Vivo Product and Services
    • 2.14.4 TOLMAR Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 TOLMAR Recent Developments/Updates
  • 2.15 Astellas
    • 2.15.1 Astellas Details
    • 2.15.2 Astellas Major Business
    • 2.15.3 Astellas Drug Delivery System in Vivo Product and Services
    • 2.15.4 Astellas Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Astellas Recent Developments/Updates
  • 2.16 Covis Pharma
    • 2.16.1 Covis Pharma Details
    • 2.16.2 Covis Pharma Major Business
    • 2.16.3 Covis Pharma Drug Delivery System in Vivo Product and Services
    • 2.16.4 Covis Pharma Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Covis Pharma Recent Developments/Updates
  • 2.17 AbbVie
    • 2.17.1 AbbVie Details
    • 2.17.2 AbbVie Major Business
    • 2.17.3 AbbVie Drug Delivery System in Vivo Product and Services
    • 2.17.4 AbbVie Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 AbbVie Recent Developments/Updates
  • 2.18 Dr Reddy
    • 2.18.1 Dr Reddy Details
    • 2.18.2 Dr Reddy Major Business
    • 2.18.3 Dr Reddy Drug Delivery System in Vivo Product and Services
    • 2.18.4 Dr Reddy Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Dr Reddy Recent Developments/Updates
  • 2.19 AstraZeneca
    • 2.19.1 AstraZeneca Details
    • 2.19.2 AstraZeneca Major Business
    • 2.19.3 AstraZeneca Drug Delivery System in Vivo Product and Services
    • 2.19.4 AstraZeneca Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 AstraZeneca Recent Developments/Updates
  • 2.20 Aspen Pharmacare
    • 2.20.1 Aspen Pharmacare Details
    • 2.20.2 Aspen Pharmacare Major Business
    • 2.20.3 Aspen Pharmacare Drug Delivery System in Vivo Product and Services
    • 2.20.4 Aspen Pharmacare Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Aspen Pharmacare Recent Developments/Updates
  • 2.21 Acrotech Biopharma
    • 2.21.1 Acrotech Biopharma Details
    • 2.21.2 Acrotech Biopharma Major Business
    • 2.21.3 Acrotech Biopharma Drug Delivery System in Vivo Product and Services
    • 2.21.4 Acrotech Biopharma Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Acrotech Biopharma Recent Developments/Updates
  • 2.22 TWi Pharmaceuticals(Bora Pharma)
    • 2.22.1 TWi Pharmaceuticals(Bora Pharma) Details
    • 2.22.2 TWi Pharmaceuticals(Bora Pharma) Major Business
    • 2.22.3 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Product and Services
    • 2.22.4 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 TWi Pharmaceuticals(Bora Pharma) Recent Developments/Updates

3 Competitive Environment: Drug Delivery System in Vivo by Manufacturer

  • 3.1 Global Drug Delivery System in Vivo Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Drug Delivery System in Vivo Revenue by Manufacturer (2021-2026)
  • 3.3 Global Drug Delivery System in Vivo Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Drug Delivery System in Vivo by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Drug Delivery System in Vivo Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Drug Delivery System in Vivo Manufacturer Market Share in 2025
  • 3.5 Drug Delivery System in Vivo Market: Overall Company Footprint Analysis
    • 3.5.1 Drug Delivery System in Vivo Market: Region Footprint
    • 3.5.2 Drug Delivery System in Vivo Market: Company Product Type Footprint
    • 3.5.3 Drug Delivery System in Vivo Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug Delivery System in Vivo Market Size by Region
    • 4.1.1 Global Drug Delivery System in Vivo Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Drug Delivery System in Vivo Consumption Value by Region (2021-2032)
    • 4.1.3 Global Drug Delivery System in Vivo Average Price by Region (2021-2032)
  • 4.2 North America Drug Delivery System in Vivo Consumption Value (2021-2032)
  • 4.3 Europe Drug Delivery System in Vivo Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Drug Delivery System in Vivo Consumption Value (2021-2032)
  • 4.5 South America Drug Delivery System in Vivo Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Drug Delivery System in Vivo Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Drug Delivery System in Vivo Sales Quantity by Type (2021-2032)
  • 5.2 Global Drug Delivery System in Vivo Consumption Value by Type (2021-2032)
  • 5.3 Global Drug Delivery System in Vivo Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Drug Delivery System in Vivo Sales Quantity by Application (2021-2032)
  • 6.2 Global Drug Delivery System in Vivo Consumption Value by Application (2021-2032)
  • 6.3 Global Drug Delivery System in Vivo Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Drug Delivery System in Vivo Sales Quantity by Type (2021-2032)
  • 7.2 North America Drug Delivery System in Vivo Sales Quantity by Application (2021-2032)
  • 7.3 North America Drug Delivery System in Vivo Market Size by Country
    • 7.3.1 North America Drug Delivery System in Vivo Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Drug Delivery System in Vivo Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Drug Delivery System in Vivo Sales Quantity by Type (2021-2032)
  • 8.2 Europe Drug Delivery System in Vivo Sales Quantity by Application (2021-2032)
  • 8.3 Europe Drug Delivery System in Vivo Market Size by Country
    • 8.3.1 Europe Drug Delivery System in Vivo Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Drug Delivery System in Vivo Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug Delivery System in Vivo Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Drug Delivery System in Vivo Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Drug Delivery System in Vivo Market Size by Region
    • 9.3.1 Asia-Pacific Drug Delivery System in Vivo Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Drug Delivery System in Vivo Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Drug Delivery System in Vivo Sales Quantity by Type (2021-2032)
  • 10.2 South America Drug Delivery System in Vivo Sales Quantity by Application (2021-2032)
  • 10.3 South America Drug Delivery System in Vivo Market Size by Country
    • 10.3.1 South America Drug Delivery System in Vivo Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Drug Delivery System in Vivo Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug Delivery System in Vivo Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Drug Delivery System in Vivo Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Drug Delivery System in Vivo Market Size by Country
    • 11.3.1 Middle East & Africa Drug Delivery System in Vivo Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Drug Delivery System in Vivo Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Drug Delivery System in Vivo Market Drivers
  • 12.2 Drug Delivery System in Vivo Market Restraints
  • 12.3 Drug Delivery System in Vivo Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug Delivery System in Vivo and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug Delivery System in Vivo
  • 13.3 Drug Delivery System in Vivo Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug Delivery System in Vivo Typical Distributors
  • 14.3 Drug Delivery System in Vivo Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug Delivery System in Vivo market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Drug Delivery System (DDS) refers to a technical system that comprehensively regulates the distribution of drugs in the body in terms of space, time and dosage. Its goal is to deliver the right amount of drugs to the right location at the right time, thereby increasing drug utilization efficiency, improving efficacy, reducing costs, and reducing side effects.
    This report is a detailed and comprehensive analysis for global Drug Delivery System in Vivo market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug Delivery System in Vivo market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug Delivery System in Vivo market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug Delivery System in Vivo market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug Delivery System in Vivo market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug Delivery System in Vivo
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug Delivery System in Vivo market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Drug Delivery System in Vivo market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Carrier Formulation Delivery
    Targeted Delivery
    Market segment by Application
    Small Molecule Drug
    Proteins and Peptides
    Antibody
    Nucleic Acids
    Others
    Major players covered
    Amgen
    Teva
    Roche
    UCB (Union Chimique Belge)
    Celgene
    Merck
    Gilead Sciences
    Sanofi
    Pfizer
    Takeda
    Bausch&Lomb
    Samyang Biopharmaceuticals
    Johnson & Johnson
    TOLMAR
    Astellas
    Covis Pharma
    AbbVie
    Dr Reddy
    AstraZeneca
    Aspen Pharmacare
    Acrotech Biopharma
    TWi Pharmaceuticals(Bora Pharma)
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Drug Delivery System in Vivo product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Drug Delivery System in Vivo, with price, sales quantity, revenue, and global market share of Drug Delivery System in Vivo from 2021 to 2026.
    Chapter 3, the Drug Delivery System in Vivo competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Drug Delivery System in Vivo breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug Delivery System in Vivo market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Delivery System in Vivo.
    Chapter 14 and 15, to describe Drug Delivery System in Vivo sales channel, distributors, customers, research findings and conclusion.

    Buy now